Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic Cancer

NCT03906357 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Interventions

DRUG: Pemigatinib

Sponsor

Incyte Corporation

Collaborators

[object Object]